Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry C Kitchener

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Plos Genetics|February 21, 2012
The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancerJoanna Zhuang, Allison Jones, Shih-Han Lee, et al.
The Lancet. Oncology|June 23, 2009
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trialHenry C Kitchener, Maribel Almonte, Claire Thomson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III TrialSarah J Kitson, Zoe Maskell, Vanitha N Sivalingam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 3, 2016
Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studiesSarah Kitson, Vanitha N Sivalingam, James Bolton, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiativeEllen Stelloo, Tjalling Bosse, Remi A Nout, et al.
International Journal of Cancer|October 6, 2018
The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer riskMichelle L MacKintosh, Abigail E Derbyshire, Rhona J McVey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccinationLucy J C Smyth, Mariëtte I E Van Poelgeest, Emma J Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancerAndreas M Kaufmann, Peter L Stern, Elaine M Rankin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2018
Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiativeAurélie Auguste, Catherine Genestie, Marco De Bruyn, et al.
Gynecologic Oncology|September 6, 2016
Working together to shape the endometrial cancer research agenda: The top ten unanswered research questionsY Louise Wan, Rachel Beverley-Stevenson, Daloni Carlisle, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Plos Genetics|February 21, 2012
The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancerJoanna Zhuang, Allison Jones, Shih-Han Lee, et al.
The Lancet. Oncology|June 23, 2009
HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trialHenry C Kitchener, Maribel Almonte, Claire Thomson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III TrialSarah J Kitson, Zoe Maskell, Vanitha N Sivalingam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 3, 2016
Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studiesSarah Kitson, Vanitha N Sivalingam, James Bolton, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiativeEllen Stelloo, Tjalling Bosse, Remi A Nout, et al.
International Journal of Cancer|October 6, 2018
The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer riskMichelle L MacKintosh, Abigail E Derbyshire, Rhona J McVey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccinationLucy J C Smyth, Mariëtte I E Van Poelgeest, Emma J Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancerAndreas M Kaufmann, Peter L Stern, Elaine M Rankin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2018
Refinement of high-risk endometrial cancer classification using DNA damage response biomarkers: a TransPORTEC initiativeAurélie Auguste, Catherine Genestie, Marco De Bruyn, et al.
Gynecologic Oncology|September 6, 2016
Working together to shape the endometrial cancer research agenda: The top ten unanswered research questionsY Louise Wan, Rachel Beverley-Stevenson, Daloni Carlisle, et al.
Pageof 9